CTLA-4——不起共刺激作用的分子：通过抑制作用调节T细胞反应 - Suppr

CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.

作者信息

Chambers C A, Allison J P

机构信息

Howard Hughes Research Institute, Division of Immunology, Department of Molecular and Cellular Biology, University of California, Berkeley, California 94720, USA.

出版信息

Cold Spring Harb Symp Quant Biol. 1999;64:303-12. doi: 10.1101/sqb.1999.64.303.

DOI:10.1101/sqb.1999.64.303

PMID:11232300

Abstract

摘要

相似文献

CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.

Cold Spring Harb Symp Quant Biol. 1999;64:303-12. doi: 10.1101/sqb.1999.64.303.

The role of CTLA-4 in the regulation and initiation of T-cell responses.

Immunol Rev. 1996 Oct;153:27-46. doi: 10.1111/j.1600-065x.1996.tb00919.x.

CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.

Res Immunol. 1995 Mar-Apr;146(3):130-40. doi: 10.1016/0923-2494(96)80246-x.

Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses.

Adv Immunol. 1996;62:131-66. doi: 10.1016/s0065-2776(08)60429-0.

Costimulatory regulation of T cell function.

Curr Opin Cell Biol. 1999 Apr;11(2):203-10. doi: 10.1016/s0955-0674(99)80027-1.

The role of CTLA-4 in the regulation of T cell immune responses.

Immunol Cell Biol. 1999 Feb;77(1):1-10. doi: 10.1046/j.1440-1711.1999.00795.x.

CTLA-4 and T cell activation.

Curr Opin Immunol. 1999 Jun;11(3):294-300. doi: 10.1016/s0952-7915(99)80047-8.

CD28, CTLA-4 and their ligands: who does what and to whom?

Immunology. 2000 Oct;101(2):169-77. doi: 10.1046/j.1365-2567.2000.00121.x.

Lymphocyte activation: T-cell regulation by CTLA-4.

Curr Biol. 1996 Apr 1;6(4):398-400. doi: 10.1016/s0960-9822(02)00506-7.

New molecules on dendritic cells and their interactions with T lymphocytes.

Adv Exp Med Biol. 1995;378:351-4. doi: 10.1007/978-1-4615-1971-3_78.

引用本文的文献

Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial.

Contemp Clin Trials Commun. 2020 May 29;19:100575. doi: 10.1016/j.conctc.2020.100575. eCollection 2020 Sep.

The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity.

Cell Res. 2020 Apr;30(4):285-299. doi: 10.1038/s41422-020-0277-x. Epub 2020 Jan 23.

Immune Cell Identity: Perspective from a Palimpsest.

Perspect Biol Med. 2015 Spring;58(2):205-28. doi: 10.1353/pbm.2015.0020.

Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis.

Pharmacogenomics J. 2016 Aug;16(4):336-40. doi: 10.1038/tpj.2015.53. Epub 2015 Jul 21.

Abatacept in psoriatic arthritis: Case report and short review.

J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S29-32. doi: 10.4103/0976-500X.120943.

Ipilimumab: controversies in its development, utility and autoimmune adverse events.

Cancer Immunol Immunother. 2009 May;58(5):823-30. doi: 10.1007/s00262-008-0653-8. Epub 2009 Feb 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.

Cold Spring Harb Symp Quant Biol. 1999;64:303-12. doi: 10.1101/sqb.1999.64.303.

The role of CTLA-4 in the regulation and initiation of T-cell responses.

Immunol Rev. 1996 Oct;153:27-46. doi: 10.1111/j.1600-065x.1996.tb00919.x.

CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.

Res Immunol. 1995 Mar-Apr;146(3):130-40. doi: 10.1016/0923-2494(96)80246-x.

Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses.

Adv Immunol. 1996;62:131-66. doi: 10.1016/s0065-2776(08)60429-0.

Costimulatory regulation of T cell function.

Curr Opin Cell Biol. 1999 Apr;11(2):203-10. doi: 10.1016/s0955-0674(99)80027-1.

The role of CTLA-4 in the regulation of T cell immune responses.

Immunol Cell Biol. 1999 Feb;77(1):1-10. doi: 10.1046/j.1440-1711.1999.00795.x.

CTLA-4 and T cell activation.

Curr Opin Immunol. 1999 Jun;11(3):294-300. doi: 10.1016/s0952-7915(99)80047-8.

CD28, CTLA-4 and their ligands: who does what and to whom?

Immunology. 2000 Oct;101(2):169-77. doi: 10.1046/j.1365-2567.2000.00121.x.

Lymphocyte activation: T-cell regulation by CTLA-4.

Curr Biol. 1996 Apr 1;6(4):398-400. doi: 10.1016/s0960-9822(02)00506-7.

New molecules on dendritic cells and their interactions with T lymphocytes.

Adv Exp Med Biol. 1995;378:351-4. doi: 10.1007/978-1-4615-1971-3_78.

引用本文的文献

Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial.

Contemp Clin Trials Commun. 2020 May 29;19:100575. doi: 10.1016/j.conctc.2020.100575. eCollection 2020 Sep.

The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity.

Cell Res. 2020 Apr;30(4):285-299. doi: 10.1038/s41422-020-0277-x. Epub 2020 Jan 23.

Immune Cell Identity: Perspective from a Palimpsest.

Perspect Biol Med. 2015 Spring;58(2):205-28. doi: 10.1353/pbm.2015.0020.

Paradoxical psoriasiform reactions to anti-TNFα drugs are associated with genetic polymorphisms in patients with psoriasis.

Pharmacogenomics J. 2016 Aug;16(4):336-40. doi: 10.1038/tpj.2015.53. Epub 2015 Jul 21.

Abatacept in psoriatic arthritis: Case report and short review.

J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S29-32. doi: 10.4103/0976-500X.120943.

Ipilimumab: controversies in its development, utility and autoimmune adverse events.

Cancer Immunol Immunother. 2009 May;58(5):823-30. doi: 10.1007/s00262-008-0653-8. Epub 2009 Feb 6.

CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.

作者信息

机构信息

出版信息

相似文献

引用本文的文献